Letters
Statins for people at low risk
N-of-1 approach to determine when adverse effects are caused by statins
BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5281 (Published 07 October 2015) Cite this as: BMJ 2015;351:h5281
- Shah Ebrahim, honorary professor of public health1,
- George Davey Smith, director2
- 1London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
- 2Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK
- shah.ebrahim{at}lshtm.ac.uk
McPherson finds it shocking that a Cochrane review group is not interested in seeking data on adverse events associated with statins.1 If he read our Cochrane reviews on statins he would see that findings related to adverse events are reported.2 What is more shocking is that a systematic review of the adverse effects of statins using observational and randomised trial evidence that we submitted to The BMJ …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.